Abstract

ABSTRACT This study provides novel insights into optimizing the integral treatment process, contributing to ROC treatment strategies. A comprehensive treatment approach for reverse osmosis concentrate (ROC) from pharmaceutical wastewater was investigated using an integral system consisting of a coagulation-flocculation and photolysis process. Ferric chloride (FC) and poly-aluminum chloride (PAC) are examined as coagulants within the range (0.1–1) gL−1, focusing on turbidity, chemical oxygen demand (COD), and total organic carbon (TOC) removal. The findings show that the optimal FeCl3 dosage is 0.4 gL−1, achieving significant turbidity reduction to 1 NTU. PAC at 0.2 gL−1 is optimal, reducing turbidity to 1 NTU and exhibiting non-linear behavior in COD and TOC removal, introducing them as a starting point to the post-treatment. Photolysis of treated samples at pH 7 yields COD reductions of 60.5% for PAC and 79.5% for FC, with respective TOC reductions of 79.5% and 75.23% over 360 min. At (pH 3.5) showed a significant reduction in the COD and TOC of treated ROC. The FC coagulant could decrease the COD from 261 to 5 mgL−1 (98% COD removal) and the TOC from 143.9 to 5 mgL−1 (74.8% TOC removal). The FAC coagulant could decrease the COD from 675 to 39 mgL−1 (93% COD removal) and the TOC from 186 to 13.1 mgL−1 (69.7% TOC removal). The conventional oxidant (H2O2) at optimal dosages enhanced COD and TOC removal at pH 7, with treated PAC and FeCl3 achieving 81.8% and 97.2% COD reduction and 89% and 98% TOC reduction at 360 minutes. These results were supported by the cost analysis in which this system was cost effective manner. This system can offer a solution for the efficient treatment of other types of industrial wastewater and open the door to new applications for water reuse on a broad scale, contributing to global water sustainability.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.